REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Trading 09-23 09:37:45

78.950

-0.400

-0.50%

High80.100	Low78.800	Vol100.00K
Open80.000	D1 Closing79.350	Amplitude1.64%
Mkt Cap44.50B	Tradable Cap16.47B	Total Shares563.61M
T/O7.95M	T/O Rate0.05%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":78.95,"timestamp":1790127451547,"preClose":79.35,"halted":0,"volume":100000,"delay":0,"changeRate":-0.0050409577819784685,"floatShares":208581239,"shares":563608243,"eps":1.5105042590239544,"marketStatus":"Trading","change":-0.4,"latestTime":"09-23 09:37:45","open":80,"high":80.1,"low":78.8,"amount":7951525,"amplitude":0.016383,"askPrice":78.95,"askSize":1500,"bidPrice":78.9,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":12.161823870597834,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1790136000000},"marketStatusCode":2,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":79.35,"openAndCloseTimeList":[[1790127000000,1790136000000],[1790139600000,1790150400000]],"volumeRatio":1.478931,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":123.96,"timestamp":1790127463000,"preClose":125.11,"halted":0,"volume":609800,"delay":0,"premium":"-45.61"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"1125223612","title":"HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125223612","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125223612?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:59","pubTimestamp":1789955946,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks rose across the board. $LEPU BIO(02157)$, $INNOCARE(09969)$ and $AKESO(09926)$ gained over 7%, while $REMEGEN(09995)$, $EVEREST MED(01952)$, $INNOVENT BIO(01801)$, $GENSCRIPT BIO(01548)$ and $SKB BIO(06990)$ rose over 6%, $3SBIO(01530)$ advanced over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","09926","09995","01952","09969","02157","01548","01530","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183071595","title":"Movement Alert｜REMEGEN Rises 5.35% in Regular Trading, RC148 Lung Cancer Clinical Data Debut at World Lung Cancer Conference Draws Market Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=1183071595","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183071595?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:42","pubTimestamp":1789954951,"startTime":"0","endTime":"0","summary":"On September 21, REMEGEN rose 5.35% in regular trading, trading at HK$78.75/share, with turnover of HK$71.61 million.On the news front, the PD-1/VEGF bispecific antibody RC148, co-developed by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Surges on RC148 Lung Cancer Data; CLSA Ups Target to HK$144.8","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113110252","title":"RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1113110252","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113110252?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:20","pubTimestamp":1789626032,"startTime":"0","endTime":"0","summary":"The valuation of innovative drug companies is fundamentally anchored to their pipeline value, and for RemeGen, the PD-1/VEGF bispecific antibody RC148—its core asset in the tumor immunotherapy...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","IE00BPRC5H50.USD","09926","LU2148510915.USD","688331","LU0540923850.HKD","LU2328871848.SGD","LU1969619763.USD","KURE","LU1961090484.USD","LU1064130708.USD","LU1794554557.SGD","LU2399975544.HKD","BK0239","LU1720050803.USD","LU2476274308.USD","BK1161","LU0634319403.HKD","LU0348825331.USD","LU0417516738.SGD","09995","LU1064131003.USD","LU0417516571.SGD","LU2778985437.USD","LU0348767384.USD","LU0348827113.USD","LU0348735423.USD","IE00B5MMRT66.SGD","LU0417516902.SGD","LU2488822045.USD","LU0561508036.HKD","LU0348766576.USD","LU0348783233.USD","LU0348784397.USD","BK1583","LU2476274720.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU1152091168.USD","LU0140636845.USD","LU1813983027.USD","LU2097828631.EUR","LU2097828805.USD","LU1328277881.USD","BK1191","IE0008368742.USD","09995","BK1161","BK1515","LNGR","IE00B5MMRT66.SGD","LU0315179316.USD","LU0067412154.USD","LU0149534421.HKD","LU1960683339.HKD","KCAI","LU1951186391.HKD","01801","BK1589","06978","LU0326950275.SGD","BK1574","LU0072913022.USD","LU0607220059.USD","IE00BZ08YS42.EUR","LU0463099449.HKD","LU1226288170.HKD","MEDX","PEVC","BK1583","IE00B031HY20.USD","LU2488822045.USD","MCRO","IE00BZ08YT58.USD","LU0502904849.HKD","LU1152091754.HKD","LU1969619763.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU2097828557.USD","IE0008369823.USD","SG9999004220.SGD","LU1226287792.SGD","01093","LU0455707207.USD","LU1807302812.USD","LU2097828714.EUR","LU2242644610.SGD","LU2328871848.SGD","LU2039709279.SGD","HK0000165453.HKD","LU1226287875.USD","02157","IBBQ","KURE","LU0314109678.HKD","LU1226287529.USD","LU2097828474.EUR","LU1831875114.USD","LU0244354667.USD","BK1521","VXUS","WRTH","BK4588","159992","LU0880133367.SGD","BK4585","LU1188198961.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","09995","LU2328871848.SGD","159992","KSTR","LU2488822045.USD","MEDX","LNGR","IBBQ","LU2148510915.USD","BK0239","LU1064131003.USD","BK1583","LU1064130708.USD","BK1161","688331","LU1969619763.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188413163","title":"RemeGen Maintains Stable Share Base; Minor A-Share Buyback Adds to Treasury in August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1188413163","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188413163?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:44","pubTimestamp":1788515048,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biopharmaceutical company RemeGen Co., Ltd. released its Monthly Return on Movements in Securities for August 2026, showing a largely unchanged share structure with a small...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118027728","title":"REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August","url":"https://stock-news.laohu8.com/highlight/detail?id=1118027728","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118027728?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:04","pubTimestamp":1788350652,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has released an announcement detailing its share repurchase activities.As of August 31, 2026, the company had repurchased a cumulative total of 41,000 A-shares through the Shanghai...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","03188","02846","LU1064130708.USD","09995","BK1147","688331","BK1583","03130","LU2328871848.SGD","399300","LU2148510915.USD","83188","159982","LU1969619763.USD","BK1161","LU2488822045.USD","02827","82846","07233","BK0239","BK1574","83130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164591890","title":"Executive Director Wang Yuxiao Reduces Stake in Remegen (09995) by 13,500 Shares at Approximately HK$81.54 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1164591890","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164591890?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:46","pubTimestamp":1788349577,"startTime":"0","endTime":"0","summary":"According to the latest disclosures from the Hong Kong Stock Exchange, on August 27, executive director Wang Yuxiao sold 13,500 shares of Remegen (09995) at an average price of HK$81.5352 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU2148510915.USD","EWH","LU1064131003.USD","BK1574","LU1969619763.USD","BK1161","09995","BK1583","688331","LU1064130708.USD","LU2488822045.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119974337","title":"Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1119974337","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119974337?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:44","pubTimestamp":1788263056,"startTime":"0","endTime":"0","summary":"Hong Kong Exchange records show that on August 26, Executive Director Wang Yuxiao sold 6,500 shares of Remegen (09995) at an average price of HK$82 per share, totaling HK$533,000.Following the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2148510915.USD","09995","EWH","LU1064130708.USD","LU2488822045.USD","LU2328871848.SGD","688331","LU1969619763.USD","BK1574","BK1161","BK1583","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184712","title":"RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:43","pubTimestamp":1787741007,"startTime":"0","endTime":"0","summary":"RemeGen stock closed at HK$80.40 on Wednesday, only slightly higher over the past week, even as the latest earnings landed with a jolt. The headline is simple: profitability in Q2 looks striking on paper, with basic earnings per share of ¥7.81 driven by net income of ¥4,334.28m. Yet the stock still trades on a trailing P/E of 6.6x while Hong Kong biotech peers sit far higher. The sentiment gap today relates to investors questioning how much of that earnings power is durable and how much the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2328871848.SGD","BK1574","FEBU","VOTE","DECU","VGFPF","BK1161","09995","LU1969619763.USD","RGLO","JOYT","GXDW","BK1583","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120378751","title":"Citi Lifts REMEGEN Price Target to HK$127.7, Keeps Buy/High-Risk Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1120378751","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120378751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:16","pubTimestamp":1787735782,"startTime":"0","endTime":"0","summary":"Citi has issued a research report highlighting that REMEGEN (09995) posted a 433% year-on-year revenue surge in the first half, swinging to a profit of RMB 4.66 billion. Management noted that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU0130102774.USD","LU2488822045.USD","BK4207","LU0648001328.SGD","09995","LU1969619763.USD","LU0314106906.USD","C","LU2125154778.USD","FTXO","LU2417539215.USD","LU1144417596.USD","LU2328871848.SGD","LU0130517989.USD","LU0980610538.SGD","LU1244550494.USD","LU0203345920.USD","BK0239","LU1506573853.SGD","LU2236285917.USD","TFNS","LU0052756011.USD","LU1064130708.USD","EWH","LU1162221912.USD","LU0072461881.USD","LU1267930227.SGD","LU1668664300.SGD","IE00BSNM7G36.USD","LU2125154935.USD","LU1244550221.USD","BK1583","688331","IYF","BK4585","LU0106831901.USD","LU2360032135.SGD","LU2456880835.USD","LU0098860793.USD","LU0128525689.USD","LU2148510915.USD","BK1574","LU0310800965.SGD","LU0203347892.USD","LU1064131003.USD","LU0162691827.USD","LU2462157665.USD","LU0170899867.USD","BK4534","BK4566","LU0477156953.USD","BK4588","BK4559","BK1161","LU1791807156.HKD","LU1244550577.SGD","LU1366192091.USD","LU1201861249.SGD","LU1074936037.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155760828","title":"CLSA Raises REMEGEN Price Target to HK$144.8, Reiterates Outperform Rating on Strong Q2 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1155760828","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155760828?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:28","pubTimestamp":1787732904,"startTime":"0","endTime":"0","summary":"CLSA has released a research report highlighting that REMEGEN (09995) delivered a remarkable 808.6% year-on-year sales growth in the second quarter of 2026, reaching a net profit of RMB 4.334...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","688331","BK1583","BK1574","LU1064130708.USD","LU1969619763.USD","LU2328871848.SGD","BK1161","LU2488822045.USD","EWH","LU2148510915.USD","BK0239","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334991","title":"HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334991","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708820,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. CANSINOBIO surged 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%.On the news front, $CANSINOBIO(06185)$ announced on August 25 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","01672","03759","06606","09688","09966","02268","03347","09995","09606","02137","06978","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109345562","title":"Movement Alert｜REMEGEN Rises 5.04% in Regular Trading, Interim Results Turn Profitable Amid Biotech Sector Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1109345562","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109345562?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:39","pubTimestamp":1787708365,"startTime":"0","endTime":"0","summary":"On August 26, REMEGEN rose 5.04% in regular trading, trading at HK$83.7/share, with turnover of HK$86.20 million.On the news front, the company disclosed its interim report on August 24, reporting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Soars on AbbVie Deal Profit Turnaround","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","09995","LU2065169927.USD","LU0323239441.USD","LU2272731600.USD","NVDY","LU2954938101.SGD","LU1066051811.HKD","SG9999014575.USD","BK4558","LU0057025933.USD","LU1720051108.HKD","LU0353189680.USD","LU0203201768.USD","BK4581","LU1048596156.SGD","LU0348735423.USD","ONLN","SGXZ99366536.SGD","LU1153585028.USD","LU1992135472.HKD","BK4504","LU0320764599.SGD","BK1615","BK1509","LU2272731865.HKD","LU2111349929.HKD","LU0197773160.USD","LU2125909759.SGD","IE00B19Z9505.USD","HK0000819398.USD","BK4592","LU2168564149.EUR","LU0345768153.USD","SG9999001424.SGD","LU0545039389.USD","LU0823421416.USD","ESUM","LU0109392836.USD","LU2491050154.USD","IE0009356076.USD","LU0072462426.USD","LU0128526141.USD","LU2106854487.HKD","01316","LU0787776722.HKD","89888","BK1575","LU2413666426.HKD","LU2471134879.HKD","LU1815336760.USD","IE000Q6AESB8.SGD","LU2237443978.SGD","LU1861127337.USD","TEK","NVDU","LU0354030511.USD","BK4605","SOXY","LU0345770308.USD","CLSE","IETC","LU2552382058.USD","IE00BFMHRM44.USD","LU0323240290.USD","LU1366333091.USD","LU0672654240.SGD","LU2394011477.USD","LU0274383008.USD","LU1008478684.HKD","LU2471134796.USD","IXN","LU2089284900.SGD","LU2237443549.SGD","CHAT","LU1069344957.HKD","HK0000306685.HKD","LU1328277881.USD","BK1618","SNVDAmain","LU1064131342.USD","LU0211977185.USD","SG9999014567.USD","IE00B4YYXB79.USD","BK1518","SG9999002828.SGD","LU3102509885.SGD","IE00BMPRXR70.SGD","BK4503","LU0164865239.USD","LU1861215975.USD","LU0880133367.SGD","LU0029874061.USD","LU1116320737.USD","LU0345769128.USD","AIPI","LU2322448791.USD","DRAG","LU2756315318.SGD","NVDQ","LU1815333072.USD","LU2746668461.USD","NVDG","NVYY","LU2473716301.USD","LU0323591593.USD","LU2242650005.HKD","NVD","IE00BN29S564.USD","LU2361044865.SGD","LU1242518931.SGD","SGXZ51526630.SGD","NVIW.SI","LU0417516738.SGD","LU1242518857.USD","LU2458330243.SGD","LU0048584097.USD","IE0034235295.USD","LU2286300806.USD","LU2028103732.USD","BK1144","LU0820561818.USD","LU0320765059.SGD","SG9999015978.USD","LU1989764748.USD","LU1316542783.SGD","LU0211327993.USD","IE0034224299.USD","USXF","LU0052750758.USD","LU1803068979.SGD","IE00BQXX3D17.EUR","01888","LU0348814723.USD","LU1868836757.USD","LU2092627202.USD","LU1280957306.USD","LU0274383776.USD","IE00BJTD4V19.USD","LU0359202008.SGD","LU2279689827.SGD","SOXQ","LU0345770993.USD","LU1868836914.USD","LU1244550577.SGD","LU0143551892.USD","SG9999014880.SGD","LU1282649141.HKD","LU0463099449.HKD","LU1066051498.USD","NULC","SG9999014559.SGD","SNVDA2609","002821","BK4505","LU2271345857.HKD","BK1609","LU0052756011.USD","DIPS","LU0307460666.USD","688331","LU0310800965.SGD","LU0708995401.HKD","LU1645745479.HKD","NVII","LU2471134523.USD","LU1923622614.USD","LU0640476718.USD","LU1211504680.USD","LU1232071149.USD","LU1127390331.HKD","LU0651946864.USD","LU1934455277.USD","ABFL","SNVD.UK","LU0456846285.SGD","06869","LU2168564222.USD","LU2168563687.JPY","THMR","LU2462157665.USD","LU1069347547.HKD","LU1989764664.SGD","LU0738911758.USD","HK0000320223.HKD","002703","LU2249611893.SGD","09888","IE00BMPRXQ63.HKD","LU0856984785.SGD","METV","IE00BQXX3F31.USD","BK4550","BK4588","LU1105468828.SGD","LU1935042488.USD","BK4502","LU0708994859.HKD","SG9999015986.USD","LU2347655073.USD","BK1132","BK4598","LU0345769631.USD","LU0648948544.HKD","LU1670756490.USD","LU0124676726.USD","LU2237443622.USD","LU2328871848.SGD","LU2065171311.SGD","IE00BYXW3230.USD","LU0823414551.USD","LU0823434583.USD","LU0965509010.AUD","LU2077746001.SGD","LU1328615791.USD","LU2351347302.SGD","IE00BK4W5L77.USD","LU0395794307.EUR","LU2750360997.AUD","LU0210528500.USD","BK1589","LU1989772923.USD","SG9999014542.SGD","LU2360032135.SGD","LU0133085943.USD","LU1674673428.USD","LU1551013342.USD","LU1244550494.USD","LU1914381329.SGD","01797","CMAG","IE00BKPKM429.USD","LU0359201885.HKD","LU1935043023.USD","LU2191332357.HKD","LU1037948897.HKD","LU1496350502.SGD","NVDB","LU2452424414.USD","IE00BJLML261.HKD","LU1804176565.USD","LU2361044949.HKD","SGXZ31699556.SGD","LU0819121731.USD","LU1791710582.SGD","IE00B3M56506.USD","LU1119994496.HKD","IE00B775SV38.USD","LU0882574139.USD","LU1235294995.USD","LU2237957902.USD","LU0957791311.USD","IE00BDCRKT87.USD","ILDR","LU0501845795.SGD","LU0072913022.USD","LU2125909593.SGD","LU1814569148.SGD","SG9999002463.SGD","688428","LU1868837300.USD","LU1642822529.SGD","BK1141","LU2322448957.HKD","02268","BK4538","BK4565","LU0170899867.USD","LU1880383366.USD","LU1571399168.USD","LU0795875169.SGD","BK1170","SG9999014898.SGD","SGXZ80539844.SGD","BK4567","BK1610","JGRO","LU1839511570.USD","BK1523","LU0234572021.USD","LU1548497426.USD","SG9999004220.SGD","BK4608","LU0138981039.USD","USD","LU2237957811.SGD","LU1769817096.USD","CNEQ","IE00BJJMRY28.SGD","LU0310799852.SGD","IE0004091025.USD","01952","LU0029864427.USD","IE00BKVL7J92.USD","LU1115378108.SGD","LU0965509283.SGD","LU0326950275.SGD","LU0011850046.USD","LU1794554557.SGD","LU0417517546.SGD","LU2637965513.SGD","LU2250418816.HKD","LU1037948541.HKD","SNPE","LU1282649067.USD","LU2552382215.SGD","LU0488056044.USD","LU2294711713.HKD","LU0353189763.USD","IE0009G5SDU7.USD","HK0000532082.HKD","LU1868837136.USD","LU2065170008.USD","LU2505996509.AUD","LU1023057109.AUD","LU0081259029.USD","LU0831093199.SGD","SG9999002562.SGD","LU2860962120.EUR","LU0348816934.USD","LU0077335932.USD","LU0516423174.USD","LU0762540952.USD","IE00B5TLWC47.USD","LU2264538146.SGD","BK4141","IE00B19Z8X17.USD","LU1813983027.USD","LU1989772840.SGD","LU1721428933.USD","LU0943347566.SGD","LU1934455194.USD","LU2361045086.USD","LU2092937148.SGD","LU0868494617.USD","SG9999018857.SGD","LU1623119135.USD","BK4543","LU2097344357.USD","LU0384037296.USD","LU0072462343.USD","NVDD","LU0348723411.USD","LU2100268510.USD","01548","SOXX","BK4607","LU2125909247.SGD","KURE","KBAB","NVC","LU2272731782.SGD","LU1778281490.HKD","LU2237438978.USD","LU0417516902.SGD","LU1821325948.USD","LU0256863811.USD","LU0689626769.HKD","BBYY","IE00BZ199S13.USD","LU0820562030.AUD","LU1974910355.USD","SG9999014914.USD","LU0965509101.SGD","LU0061474705.USD","SPTE","LU0347712357.USD","LU2413666699.HKD","IE0005OL40V9.USD","LU0456827905.SGD","LU1400636491.USD","LU1699723380.USD","BK1521","IE0003U64NQ7.SGD","LU0069063385.USD","IE00BK4W5M84.HKD","LU0719512351.SGD","LU0965508806.USD","601869","LU0256863902.USD","LU1003077747.HKD","LU2108987350.USD","BK1149","LU0173614495.USD","LU0588546209.SGD","LU0797268264.HKD","LU0861579265.USD","LU1084165304.USD","LU0472753341.HKD","LU0918141887.USD","LU0197773673.USD","LU1633808545.USD","ANV","BK1587","LU0070217475.USD","LU2778985437.USD","LU0289961442.SGD","BK4534","LU0640798160.USD","BK4612","LU0823426308.USD","LU0164880469.USD","LU0082616367.USD","LU0949170772.SGD","LU1066053197.SGD","ARTY","LU1935042991.SGD","LU2087625088.SGD","LU2133065610.SGD","LU2211815571.USD","LU1282648689.USD","LU0348825331.USD","LU2381873111.SGD","LU0265550946.USD","LU2476274308.USD","TRFK","LU1282649810.SGD","LU1951198990.SGD","HK0000914660.USD","SG9999002224.SGD","LU2237443382.USD","SG9999000418.SGD","BK4579","LU0630378429.USD","NVDA","LU1732799900.SGD","BK4548","LU0234570918.USD","LU0128525929.USD","BK1576","LU0786609619.USD","LU2487616109.SGD","LU0158827781.USD","BK4585","LU0328353924.USD","LU0251132253.USD","LU0107464264.USD","SG9999017495.SGD","SMHX","07388","LU1720050803.USD","LU1066051225.USD","LU0080751232.USD","LU2226246903.HKD","LU0229945570.USD","LU0149721374.USD","LU1400636574.HKD","LU1979441026.SGD","LU0795875086.SGD","TYLG","LU1152091754.HKD","BK1191","LU2461242641.AUD","BK1161","LU2456880835.USD","09988","HK0000304805.HKD","LU1823568750.SGD","LU2083900584.USD","LU0106261372.USD","LU1267930227.SGD","LU1923622291.USD","LU0051755006.USD","LU1116320901.HKD","IE00B4JS1V06.HKD","LU0244354667.USD","LU0820561909.HKD","BK1506","BABW","LU0724617625.USD","LU0308772762.SGD","LU2929501877.USD","LU2087621335.USD","HK0000306701.USD","LU1791710400.SGD","LU0985320562.USD","LU2403377893.USD","LU2552382132.HKD","IE0004445239.USD","IE00BF5LJ272.USD","LU2999663052.SGD","BK4575","LU1923623000.USD","LU0316494557.USD","BK1228","LU0868494708.USD","LU1969619763.USD","LU0494093205.USD","LU0174119429.USD","LU1688375341.USD","LU2420271590.USD","IE00BKDWB100.SGD","LU0175139822.USD","LU2237443895.HKD","IE0034235303.USD","LU0359201612.USD","LU2430703095.HKD","IE00BHPRN162.USD","LU2047632596.USD","LU0265550359.USD","LU0327786744.USD","FDTX","LU0127658192.USD","LU2602419157.SGD","LU1366192091.USD","LU0215105999.USD","IE00B7KXQ091.USD","LU1674673691.USD","LU2089985449.USD","LU0476273544.USD","LU2462591350.SGD","LU0342679015.USD","EFIV","LU0238689110.USD","LU1267930730.SGD","SG9999015945.SGD","00148","LU0094547139.USD","VT","XLK","LU1051768304.USD","GAMR","TCHI","LU3063872942.SGD","LU1046421795.USD","LU1429558221.USD","LU1496350171.SGD","LU1202635105.USD","LU0912757837.SGD","LU0228367735.SGD","LU2125154778.USD","LU0314109678.HKD","LU2488822045.USD","LU1868836591.USD","BK4527","LU1732800096.USD","LU1323610961.USD","LU0096362180.USD","NVDS","LU0157215616.USD","LU0310800379.SGD","SG9999015358.SGD","CHPX","2NVD.UK","LU1861220033.SGD","BK4524","LU2357305700.SGD","LU0466842654.USD","LU0964807845.USD","LU1720051017.SGD","BK4220","06821","LU1481107354.HKD","LU0354030438.USD","02556","LU2023250504.SGD","LU2244417387.USD","LU0918141705.HKD","02269","LU0823421333.USD","LU2360107168.USD","SGXZ23171101.USD","IE0001KFT4U8.USD","LU2896262040.SGD","LU1035775433.USD","IE0004445015.USD","LU0106959298.USD","LU0203202063.USD","NVDX","LU2471134952.CNY","FTEC","LU0553294199.USD","LU2750360641.GBP","LU0140636845.USD","LU1880398471.USD","LU2290526834.HKD","LU0762541174.USD","LU2168564495.EUR","LU0056508442.USD","LU1831875114.USD","LU0158827948.USD","LU0053666078.USD","LU1935043536.SGD","TTXU","IE000W1ABFV2.USD","LU0287142896.SGD","BK1574","LU2592432038.USD","LU0154236417.USD","LU1051769294.HKD","LU0006306889.USD","SG9999004303.SGD","LU0511384066.AUD","LU0289960550.SGD","LU0642271901.SGD","LU0557290698.USD","FAI","HK0000304797.USD","BK4551","LU0979878070.USD","LU1046422090.SGD","BK1095","IE00B19Z8W00.USD","LU2125154935.USD","TTEQ","WISE","LU1400636657.SGD","LU0516423091.SGD","LU1629891620.HKD","LU0708995583.HKD","NVD2.UK","LU1244550221.USD","KBDCY","LFGY","IE00B5949003.HKD","IE00BD6J9T35.USD","LU0788109477.HKD","BK1516","LU1808992512.USD","LU0957808578.USD","LU0225283273.USD","LU0531971595.HKD","IE000KEQY171.SGD","LU2265009873.SGD","3NVD.UK","LU2236285917.USD","BK4535","SG9999018865.SGD","LU0181495838.USD","LU2054465674.USD","ROM","LU2023251221.USD","IE00B0JY6N72.USD","BABC","LU2148611432.USD","NVDL","SGXZ81514606.USD","LU0267386448.USD","BK4531","IE00BFSS7M15.SGD","BK1596","LU0942090050.USD","LU0067412154.USD","LU0572944931.SGD","LU0043850808.USD","NVDW","LU0198837287.USD","LU0516422366.SGD","LU1188198961.HKD","LU0097036916.USD","BK4587","LU0390134368.USD","LU2213496289.HKD","LU2125909916.SGD","LU1435385759.SGD","BK4554","LU0871576103.HKD","LU1261432733.SGD","BK4614","LU1691799644.USD","LU1934455863.HKD","SG9999014674.SGD","CLIX","BK4532","LU1048588211.SGD","LU0516422952.EUR","LU0456842615.SGD","BK1583","LU0762542818.HKD","BABA","LU2462591277.SGD","IE00BZ1G4Q59.USD","LU0047713382.USD","LU0096364046.USD","LU2187417386.USD","LU0823426480.USD","LU2347655156.SGD","IE00BJTD4N35.SGD","LU0187121727.USD","LU1935042215.USD","BK4549","HK0000914686.HKD","LU0315179316.USD","LU0726765562.USD","LU1551013425.SGD","BK4122","IE00B1BXHZ80.USD","LU0061474960.USD","BABU","LU0227179875.USD","LU0128525689.USD","LU0661504455.SGD","LU0823414478.USD","LU2097344431.USD","IE00B775H168.HKD","LU0210536198.USD","LU1144417596.USD","LU1712237335.SGD","LU1951200564.SGD","LU2242649171.HKD","NVD3.UK","SG9999015952.SGD","ESLG","LU0823434740.USD","LU1267930573.SGD","BK4526","LU0210533765.USD","BABO","LU2360106780.USD","LU2491049909.HKD","LU0079474960.USD","BK1588","LU1267930490.SGD","LU0211328371.USD","LU0276348264.USD","LU1035773651.USD","LU1983260115.SGD","LU2463028550.USD","LU0345768740.USD","IE00B3S45H60.SGD","IE00B3SWFQ91.USD","09969","LU2326559502.SGD","LU2931357623.SGD","LU0444971666.USD","BK4529","IE00BFSS8Q28.SGD","LU2433249047.HKD","GB00BDT5M118.USD","LU2505996681.GBP","LU0889565833.HKD","BABX","LU2065171402.SGD","IE000ITXATA3.USD","LU2237443465.HKD","WXXWY","BK1519","LU2430703178.SGD","MCHS","IE00BWXC8680.SGD","LU2430703251.USD","LU1152091168.USD","LU0689472784.USD","IE0034235188.USD","HK0000320264.USD","LU1917777945.USD","LU0444973449.USD","LU0109391861.USD","LU1880398554.USD","BIDU","07788","LU0651947912.USD","LU1988902786.USD","LU2417539215.USD","VGT","IE00BQXX3C00.GBP","LU2023250330.USD","BK1109","LU1145028129.USD","SG9999002232.USD","LU2746668974.SGD","SG9999014906.USD","LU0683600562.USD","LU2168564065.EUR","LU2506951792.HKD","SG9999006597.SGD","ALBmain","LU2247934214.USD","LU2756315664.SGD","LU0630378692.HKD","SG9999015341.SGD","IE00B1XK9C88.USD","LU0543330566.HKD","LU0821914370.USD","IE000YTNTUN2.SGD","LU1852331112.SGD","BK4533","01057","AIFD","FPA","LU0163747925.USD","IE00BMPRXN33.USD","LU0266013472.USD","IE0004086264.USD","LU0289739343.SGD","LU0039217434.USD","LU1992135399.USD","NVDO","SHOC","NVDS.UK","LU1718418525.SGD","LU0516422440.USD","LU2357125470.USD","LU2063271972.USD","LU2491050071.SGD","LU0251143458.SGD","IE00BDRTCR15.USD","LU0528227936.USD","AGOX","IE00BJJMRX11.SGD","LU1769817179.HKD","LU2458330169.SGD","LU1515016050.SGD","LU2039709279.SGD","LU2089283258.USD","SMH","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190936744","title":"Movement Alert｜REMEGEN Rises 5.12% in Regular Trading, H1 Earnings Show Turnaround to Profitability with Revenue Surging Over 4x","url":"https://stock-news.laohu8.com/highlight/detail?id=1190936744","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190936744?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:56","pubTimestamp":1787622992,"startTime":"0","endTime":"0","summary":"On August 25, REMEGEN rose 5.12% in regular trading, trading at HK$77.9/share, with turnover of HK$108 million.On the news front, the company disclosed its half-year report on the evening of August...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Surges as H1 Revenue Jumps 433% and Returns to Profit","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662026272","title":"RemeGen Swings to Profit in H1 as Revenue Surges Fivefold","url":"https://stock-news.laohu8.com/highlight/detail?id=2662026272","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662026272?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:36","pubTimestamp":1787618181,"startTime":"0","endTime":"0","summary":"RemeGen  posted an attributable profit of 4.66 billion yuan in the first half of 2026, rebounding from an attributable loss of 449.57 billion yuan a year ago.Earnings per share came in at 8.32 yuan, compared with a loss per share of 0.83 yuan a year earlier, according to a Monday filing with the Hong Kong Exchange.Revenue surged year over year to 5.85 billion yuan from 1.09 billion, the biopharmaceutical company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FCA","LU2488822045.USD","BK1574","688331","LU2148510915.USD","BK1161","09995","BK0239","LU1064131003.USD","BK1583","LU1969619763.USD","LU2328871848.SGD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119855590","title":"RemeGen turns profitable: H1 2026 revenue jumps 435.74% to RMB5.85 billion on AbbVie deal and core drug sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1119855590","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119855590?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:48","pubTimestamp":1787582902,"startTime":"0","endTime":"0","summary":"RemeGen (09995) reported an unaudited net profit of RMB4.66 billion for the six months ended 30 June 2026, reversing a RMB0.45 billion loss a year earlier. The swing was driven by a quintupled...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"RemeGen turns profitable: H1 2026 revenue jumps 435.74% to RMB5.85 billion on AbbVie deal and core drug sales","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174416927","title":"Movement Alert｜REMEGEN Falls 5.13% in Regular Trading, Market Questions Sustainability of One-Time Licensing Revenue Ahead of Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1174416927","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174416927?lang=en_us&edition=fundamental","pubTime":"2026-08-24 13:08","pubTimestamp":1787548116,"startTime":"0","endTime":"0","summary":"On August 24, REMEGEN fell 5.13% in regular trading, trading at 74.9 HKD/share, with turnover of HKD 184 million. The decline coincided with the board meeting convened to approve interim results for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"REMEGEN Slumps as One-Time AbbVie Licensing Revenue Sparks Doubt","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138048764","title":"Movement Alert｜REMEGEN Rises 5.2% in Regular Trading, Biotech Sector Rallies Ahead of Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1138048764","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138048764?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:45","pubTimestamp":1787190303,"startTime":"0","endTime":"0","summary":"On August 20, REMEGEN rose 5.2% in regular trading, trading at HK$83.65/share, with turnover of HK$127 million. The stock was lifted by a combination of an imminent mid-term earnings release and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Risescas Biotech Sector Rallies Ahead of Interim Results Release","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0517},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.1517},{"period":"6month","weight":-0.1044},{"period":"1year","weight":-0.237},{"period":"ytd","weight":0.1021}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.079897},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}